Posted by Michael Wonder on 12 Oct 2020
EMA publishes agenda for 12-15 October CHMP meeting
12 October 2020 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Budesonide with glycopyrronium and eformoterol fumarate dihydrate
- Fenfluramine hydrochloride
- T-cells (autologous)
- Lenalidomide
- Inclisiran
- T-cells, CD34 positive (autologous)
- Lumasiran
- Peanut allergen extract
- Rilpivirine
- Ivosidenib
- Cabotegravir
Read CHMP agenda
Posted by:
Michael Wonder